Ubs Asset Management Americas Inc Longboard Pharmaceuticals, Inc. Transaction History
Ubs Asset Management Americas Inc
- $345 Billion
- Q2 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Longboard Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 50,056 shares of LBPH stock, worth $2.99 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,056Holding current value
$2.99 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LBPH
# of Institutions
104Shares Held
34.2MCall Options Held
8.5KPut Options Held
31.1K-
Ra Capital Management, L.P. Boston, MA3.29MShares$196 Million1.34% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.94MShares$175 Million0.38% of portfolio
-
Cormorant Asset Management, LP Boston, MA2.79MShares$167 Million5.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$150 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$141 Million0.0% of portfolio
About Longboard Pharmaceuticals, Inc.
- Ticker LBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,586,000
- Market Cap $811M
- Description
- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...